Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Multiple Sclerosis, Relapsing Forms”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Large-scale testing (Phase 3)Not Yet RecruitingNCT07483632
What this trial is testing

Learn About the Safety of Diroximel Fumarate (DRF) and Dimethyl Fumarate (DMF) and Their Effects on Relapses in Pediatric Participants With Relapsing Forms of Multiple Sclerosis (RMS)

Who this might be right for
Relapsing Forms of Multiple Sclerosis
Biogen 185
Not applicableStudy completedNCT01158183
What this trial is testing

Real-World Betaseron Health Economic Outcomes Study for Relapsing Forms of Multiple Sclerosis

Who this might be right for
Multiple Sclerosis, Relapsing-Remitting
Bayer 226
Not applicableStudy completedNCT01070836
What this trial is testing

JC Virus Antibody Study of Participants With Relapsing Forms of MS Receiving Treatment With Natalizumab

Who this might be right for
Relapsing Multiple Sclerosis
Biogen 35,895
Not applicableActive Not RecruitingNCT05688436
What this trial is testing

Learn More About The Safety of Diroximel Fumarate (VUMERITY®) in Participants Who Took it During Pregnancy And About the Health of Their Babies

Who this might be right for
Multiple Sclerosis
Biogen 1,178
Post-approval studies (Phase 4)Study completedNCT01591551
What this trial is testing

NAPS-MS: NAtalizumab Effects on Parameters of Sleep in Patients With Multiple Sclerosis Experiencing Fatigue or Sleepiness

Who this might be right for
Multiple Sclerosis, Relapsing-Remitting
Cornerstone Health Care, PA 37
Post-approval studies (Phase 4)Ended earlyNCT02117050
What this trial is testing

RESOunD: REbif Satisfaction On Discontinuing Oral Dimethyl Fumarate

Who this might be right for
Multiple Sclerosis
EMD Serono 1
Large-scale testing (Phase 3)Study completedNCT01201356
What this trial is testing

Long-term Safety and Tolerability of 0.5 mg Fingolimod in Patients With Relapsing Forms of Multiple Sclerosis

Who this might be right for
Relapsing Forms of Multiple Sclerosis
Novartis Pharmaceuticals 4,125
Not applicableStudy completedNCT06251986
What this trial is testing

A Cross-sectional Study to Assess the Effectiveness and Safety of Ofatumumab (Kesimpta®) in Patients With Relapsing Multiple Sclerosis in the Spanish Clinical Practice

Who this might be right for
Relapsing Forms of Multiple Sclerosis
Novartis Pharmaceuticals 310
Large-scale testing (Phase 3)Study completedNCT01863888
What this trial is testing

Effect of Teriflunomide on Immune Cell Subsets in the Blood of Patients With Multiple Sclerosis

Who this might be right for
Multiple Sclerosis
Sanofi 70
Testing effectiveness (Phase 2)Study completedNCT00436826
What this trial is testing

Cladribine Add-on to Interferon-beta (IFN-beta) Therapy in Multiple Sclerosis (MS) Subjects With Active Disease (ONWARD)

Who this might be right for
Multiple Sclerosis
EMD Serono Research & Development Institute, Inc. 172
Testing effectiveness (Phase 2)Ended earlyNCT05049161
What this trial is testing

A Long-term Extension of Study GNC-401

Who this might be right for
Multiple Sclerosis
GeNeuro Innovation SAS 33
Testing effectiveness (Phase 2)Study completedNCT04480307
What this trial is testing

Clinical Trial Assessing Temelimab Following Rituximab Treatment in Patients With Relapsing Forms of Multiple Sclerosis

Who this might be right for
Multiple Sclerosis
GeNeuro Innovation SAS 41
Not applicableStudy completedNCT06526000
What this trial is testing

Study to Assess Changes in Immunoglobulins in Patients With Relapsing Multiple Sclerosis Treated With Anti-CD20 Therapies

Who this might be right for
Relapsing Multiple SclerosisClinically Isolated SyndromeRelapsing-remitting Multiple Sclerosis+1 more
Novartis 326
Not applicableEnded earlyNCT04948606
What this trial is testing

Exploring Diroximel Fumarate Real-world Experience in Canada and Israel

Who this might be right for
Relapsing Forms of MS
Biogen 64
Not applicableStudy completedNCT03101735
What this trial is testing

Study to Assess Resource Utilization and Quality of Life of Patients With RRMS Treated With Tecfidera in Greece

Who this might be right for
RRMS
Genesis Pharma CNS & Specialty 455
Not applicableStudy completedNCT01903291
What this trial is testing

Effectiveness of DMF and Its Impact on PROs in Suboptimal GA Responders With RMS

Who this might be right for
Relapsing Forms of Multiple Sclerosis
Biogen 333
Not applicableStudy completedNCT02021162
What this trial is testing

Effects of Gilenya (Fingolimod) on Thalamus Pathology and Cognitive Impairment in Patients With Relapsing Forms of Multiple Sclerosis

Who this might be right for
Multiple SclerosisHealthy
University at Buffalo 50
Large-scale testing (Phase 3)UnknownNCT01464905
What this trial is testing

Phase 3 Study to Evaluate Efficacy and Safety of NU100 in Patients With Relapsing Remitting Multiple Sclerosis (RRMS)

Who this might be right for
Relapsing Remitting Multiple Sclerosis
Nuron Biotech Inc. 500
Not applicableStudy completedNCT01070719
What this trial is testing

Pharmacokinetic, Immunological and Biochemical Sample Collection and Analysis of a Tysabri Patient Cohort

Who this might be right for
Multiple SclerosisRelapse
John F. Foley, MD 270
Large-scale testing (Phase 3)WithdrawnNCT02428218
What this trial is testing

Placebo-Controlled Study of the Efficacy and Safety of BG00012 in Pediatric Subjects With Relapsing-Remitting Multiple Sclerosis (RRMS)

Who this might be right for
Relapsing-Remitting Multiple SclerosisRelapsing Forms of Multiple Sclerosis
Biogen
Next Page